|
NGRN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.675900E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.517200E-03 |
| Normal-vs-Stage2 |
9.058100E-03 |
| Normal-vs-Stage3 |
1.355230E-01 |
| Normal-vs-Stage4 |
6.125800E-01 |
| Stage1-vs-Stage2 |
4.859400E-01 |
| Stage1-vs-Stage3 |
5.241800E-01 |
| Stage1-vs-Stage4 |
1.907780E-01 |
| Stage2-vs-Stage3 |
2.912600E-01 |
| Stage2-vs-Stage4 |
1.308220E-01 |
| Stage3-vs-Stage4 |
2.910400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.306430E-02 |
| Normal-vs-AfricanAmerican |
1.099430E-01 |
| Normal-vs-Asian |
5.798600E-01 |
| Caucasian-vs-AfricanAmerican |
6.000600E-01 |
| Caucasian-vs-Asian |
9.565600E-01 |
| AfricanAmerican-vs-Asian |
8.969200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.319800E-03 |
| Normal-vs-Female |
3.650600E-01 |
| Male-vs-Female |
8.905600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.604180E-01 |
| Normal-vs-Extreme_Weight |
6.977300E-03 |
| Normal-vs-Obese |
6.486000E-02 |
| Normal-vs-Extreme_Obese |
3.362200E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.198600E-01 |
| Normal_Weight-vs-Obese |
8.161400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.540800E-01 |
| Extreme_Weight-vs-Obese |
5.475400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.923200E-01 |
| Obese-vs-Extreme_Obese |
5.234200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.178210E-01 |
| Normal-vs-Age(41-60Yrs) |
3.641700E-02 |
| Normal-vs-Age(61-80Yrs) |
1.557690E-02 |
| Normal-vs-Age(81-100Yrs) |
7.117700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.660600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.646200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.637800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.842000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.882200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.161600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.453800E-02 |
| Normal-VS-Type2 PRCC |
2.573000E-04 |
| Normal-VS-KIRP CIMP |
3.145000E-01 |
| Normal-VS-Unclassified PRCC |
1.503740E-03 |
| Type1 PRCC-VS-Type2 PRCC |
7.679600E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.557650E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.441900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.856400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.237000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.371600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.181100E-04 |
| Normal-vs-N1 |
7.313800E-01 |
| Normal-vs-N2 |
7.941800E-01 |
| N0-vs-N1 |
7.116100E-02 |
| N0-vs-N2 |
6.573200E-01 |
| N1-vs-N2 |
8.534400E-01 |
|
|
